• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Value of central analysis of leucocyte depletion quality control data within the National Blood Service, England.

作者信息

Beckman Neil, Cardigan R, Wallington T, Williamson L M

机构信息

National Blood Service, Vincent Drive, Edgbaston, Birmingham, B15 2SG, UK.

出版信息

Vox Sang. 2002 Aug;83(2):110-8. doi: 10.1046/j.1423-0410.2002.00210.x.

DOI:10.1046/j.1423-0410.2002.00210.x
PMID:12201840
Abstract

BACKGROUND AND OBJECTIVES

The results of quality monitoring leucocyte counts were analysed nationally for the first 2 years of universal leucocyte depletion (LD), spanning the time-period before and after standardization of the counting and LD methods. The objectives were twofold: first to determine whether the implementation strategy was effective in achieving the LD specification (< 5 x 10(6) leucocytes in 99% of components with 95% statistical confidence); and second, whether quality monitoring was able to detect potential non-conformance.

MATERIALS AND METHODS

Residual leucocytes were counted using Beckman Coulter or Becton Dickinson (BD) flow cytometers and reagents. Data were collected into standardized analysis software (NWA Quality Analyst) for local trend analysis and checks for conformance to process specification, and collated centrally. Analysis was performed for six time-periods between January 1999 and March 2001. Specification failures were analysed to determine the likelihood of extreme failure. Statistical process monitoring was adjusted to suit LD processes.

RESULTS

Data from red cells in optimal additive solution (OAS), filtered either as whole blood or red cell concentrates, and platelet pools improved significantly over the 2-year period with specification failures falling from 0.35%, 0.48% and 0.56%, respectively, in January-June 1999 to 0.06%, 0.01% and 0.04% in January-March 2001. Specification failures in red cells in OAS LD for the period January-December 2000 showed only 0.02% with a leucocyte count of > 30 x 10(6)/unit. Extreme failures are now very rare. Monitoring methods have been effective in detecting process change and drift.

CONCLUSION

LD performance varies between different LD systems, but monitoring has proved sufficiently robust to detect processes that perform poorly. The chosen specification has been both achievable and appropriate to the systems in use. Standardization of the counting method is central to the ability to monitor and analyse results effectively across the whole service.

摘要

相似文献

1
Value of central analysis of leucocyte depletion quality control data within the National Blood Service, England.
Vox Sang. 2002 Aug;83(2):110-8. doi: 10.1046/j.1423-0410.2002.00210.x.
2
The development of a national standardized approach for the enumeration of residual leucocytes in blood components.
Vox Sang. 2002 Aug;83(2):100-9. doi: 10.1046/j.1423-0410.2002.00194.x.
3
Quality control of leucoreduced cellular blood components in France.法国白细胞去除的细胞血液成分的质量控制
Vox Sang. 2002 Feb;82(2):67-71. doi: 10.1046/j.1423-0410.2002.00139.x.
4
Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study.低水平白细胞计数:一项外部质量评估研究强调的白细胞滤除输血成分验证中的关键变量。
Clin Lab Haematol. 2001 Feb;23(1):43-51. doi: 10.1046/j.1365-2257.2001.00356.x.
5
A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.
Transfus Apher Sci. 2002 Feb;26(1):73-81. doi: 10.1016/s1473-0502(01)00147-1.
6
The United Kingdom National External Quality Assessment Scheme gating and standardization strategy for use in residual WBC counting of WBC-reduced blood components.
Transfusion. 2002 Jun;42(6):738-46. doi: 10.1046/j.1537-2995.2002.00116.x.
7
French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
Transfus Sci. 1998 Dec;19(4):333-42. doi: 10.1016/s0955-3886(98)00059-9.
8
Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.白细胞去除血液成分质量控制中的挑战及现行标准。白细胞滤除成分的质量保证挑战。
Transfus Sci. 1998 Dec;19(4):377-80. doi: 10.1016/s0955-3886(98)00073-3.
9
The use of acridine orange and glutaraldehyde-fixed chicken red blood cells for absolute counting of residual white blood cells in leuco-depleted packed red blood cells.吖啶橙和戊二醛固定的鸡红细胞用于白细胞减少的浓缩红细胞中残余白细胞的绝对计数。
Asian Pac J Allergy Immunol. 2012 Jun;30(2):123-9.
10
National French observatory of the quality of blood components for transfusion.法国国家输血用血液成分质量观测站。
Transfus Clin Biol. 2008 Jun;15(3):85-90. doi: 10.1016/j.tracli.2008.04.006. Epub 2008 Jun 3.

引用本文的文献

1
The use of a hematology analyzer with a new generation of software as an alternative to flow cytometry for enumerating residual white blood cells in blood components.使用新一代软件的血液学分析仪替代流式细胞术对血液成分中残留的白细胞进行计数。
Transfusion. 2020 Jan;60(1):155-164. doi: 10.1111/trf.15606. Epub 2019 Nov 26.